Korea Investment Corp Ionis Pharmaceuticals Inc Transaction History

Korea Investment Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$34.54 - $47.25 $1.03 Million - $1.41 Million	-29,900 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $382,590 - $574,020	-9,000 Reduced 23.14%	29,900 $1.34 Million
Q4 2020 Feb 10, 2021	BUY	$45.3 - $60.27 $203,850 - $271,215	4,500 Added 13.08%	38,900 $2.2 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $47,450 - $62,950	-1,000 Reduced 2.82%	34,400 $1.63 Million
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $103,070 - $134,310	2,200 Added 6.63%	35,400 $2.09 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $1.38 Million - $2.1 Million	33,200 New	33,200 $1.57 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.